39 Recruiting Acute Leukemia Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Acute Leukemia Studies
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
📍 New York Medical College — Valhalla, New York
View Study & Checklist ➔Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
📍 Rebecca and John Moores UCSD Cancer Center — La Jolla, California
View Study & Checklist ➔Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
📍 Hartford Healthcare Cancer Institute @ Hartford Hospital — Hartford, Connecticut
View Study & Checklist ➔ATG Plus PTCy vs ATG for CGVHD Prophylaxis
📍 Kinghorn Cancer Centre, St Vincent's Health Network — Darlinghurst, New South Wales
View Study & Checklist ➔Cancer Stem Cells in Acute Leukemia
📍 Sanford — Fargo, North Dakota
View Study & Checklist ➔A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
📍 City of Hope — Duarte, California
View Study & Checklist ➔Biomarkers in Patients With Anemia-Induced Thrombocytopenic Bleeding
📍 Juravinski Hospital — Hamilton, Ontario
View Study & Checklist ➔Umbilical Cord Blood Transplantation From Unrelated Donors
📍 Wilmot Cancer Institute — Rochester, New York
View Study & Checklist ➔A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
📍 University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔Familial Investigations of Childhood Cancer Predisposition
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
View Study & Checklist ➔Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
📍 Masonic Cancer Center at University of Minnesota — Minneapolis, Minnesota
View Study & Checklist ➔A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
View Study & Checklist ➔Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia
📍 Juravinski Cancer Centre at Hamilton Health Sciences — Hamilton, Ontario
View Study & Checklist ➔CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
📍 Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
View Study & Checklist ➔Prevention of Hospital Acquired Deconditioning in Hospitalized Acute Leukemia Patients
📍 North Shore University Hospital (NSUH) — Manhasset, New York
View Study & Checklist ➔A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
📍 City of Hope — Duarte, California
View Study & Checklist ➔Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
📍 Lucille Packard Children's Hospital of Stanford University — Palo Alto, California
View Study & Checklist ➔Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔TBI Using IMRT (VMAT or Tomotherapy) for the Prevention of Pul Toxicities in Patients Undergoing Donor SCT
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)
📍 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
View Study & Checklist ➔BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)
📍 University of Illinois Cancer Center — Chicago, Illinois
View Study & Checklist ➔